Evaluation of the Antimicrobial Fiber Reinforced Composite Resin Space Maintainer Modified With Silver Nano Particles

Sponsor
Al-Azhar University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05902975
Collaborator
(none)
24
1
2
13.8
1.7

Study Details

Study Description

Brief Summary

Fiber reinforced composite resin space maintainer

Condition or Disease Intervention/Treatment Phase
  • Device: Fiber reinforced composite resin space maintainer
N/A

Detailed Description

Evaluation of the antimicrobial fiber reinforced composite resin space maintainer modified by silver nano particles.

Study Design

Study Type:
Interventional
Actual Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Evaluation of the Antimicrobial Fiber Reinforced Composite Resin Space Maintainer Modified With Silver Nano Particles
Actual Study Start Date :
May 21, 2022
Actual Primary Completion Date :
May 15, 2023
Anticipated Study Completion Date :
Jul 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fiber reinforced composite space maintainer

12 children received fiber reinforced composite (FRC) space maintainer without silver nanoparticle.

Device: Fiber reinforced composite resin space maintainer
Bonding of fiber reinforced with composite resin on primary second molar and primary canine under rubber dam isolation

Experimental: Fiber reinforced space maintainer with silver nano particles

12 children received fiber reinforced composite (FRC) space maintainers modified with silver nanoparticles.

Device: Fiber reinforced composite resin space maintainer
Bonding of fiber reinforced with composite resin on primary second molar and primary canine under rubber dam isolation

Outcome Measures

Primary Outcome Measures

  1. Evaluation of strepetoccous mutant and lactobacilli from sample of saliva [6 month]

    Streptococcus mutants : One loop (1/1000th ml of sample) was inoculated on the Mitis Salivarius (MSA)* agar with 0.2 U/ml bacitracin and sucrose (15% w/v) bacitracin. The plates were incubated aerobically ( 5% CO2) at 37°C for 48 h.(10) For determination of S. mutans count: After 48 h , colony characteristics were studied and the number of colony forming units of SM (CFU/ml) in saliva was determined manually . Lactobacilli : One loop (1/1000th ml of sample) was inoculated on the Rogosa **SL agar plate. The plates were incubated aerobically ( 5% CO2) at 37°C for 48 h.(11) For determination of lactobacilli count: After 48 h , colony characteristics were studied and the number of colony forming units of lactobacilli (CFU/ml) in saliva was determined manually

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 9 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Premature loss of primary molar.

  • Presence of teeth on the mesial and distal sides of the extraction space.

  • Normal primary molar relation.

  • No root resorption of abutment teeth.

  • Presence of a succedaneous tooth bud.

  • Absence of pathology on the eruption track of the succedaneous tooth.

  • The age will be ranged from 4 to 9 years.

Exclusion Criteria:
  • Carious buccal and lingual surface of abutment teeth.

  • Absence of teeth on the mesial and distal sides of the extraction.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alazhar university Cairo Egypt

Sponsors and Collaborators

  • Al-Azhar University

Investigators

  • Study Director: Alaa eldin Mahmoud Abdallah, Associate professior
  • Study Director: Hamdy Mahmoud Badereldin, Lecture
  • Study Director: Ahmed Akram Elawady, Lecture

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohamed Nada Mohamed Elsadany, Mohamed nada Mohamed elsadany, Al-Azhar University
ClinicalTrials.gov Identifier:
NCT05902975
Other Study ID Numbers:
  • Space maintainer
First Posted:
Jun 15, 2023
Last Update Posted:
Jun 15, 2023
Last Verified:
Jun 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2023